Home
University of Bergen
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Alberto Ascherio foreleser
Falch Lecturer 2023: Prof. Alberto Ascherio (26.05.2023)
Hundreds showed up to this year's Falch Lecture, titled: “The Epstein-Barr virus as the leading cause multiple sclerosis and the possible viral etiology of other neurodegenerative diseases”
Prof Hans Peter Marti
UiB researchers received funding of millions for targeted treatment of chronic kidney disease. (24.05.2023)
A new research project at the Department of Clinical Medicine (K1) aims to tailor treatment to children and adolescents living with chronic kidney disease. The Norwegian Research Council has provided NOK 12 million in support for the project. 
Snapshot of the interview with Professor Tzoulis.
The importance of clinical trials (22.05.2023)
May 20 was the Clinical Trials Day, which arrives each May 20 as an opportunity for the clinical research community to pause in reflection, recognition, and admiration of all that has been accomplished thanks to clinical trials and the people behind them. The Norwegian Parkinson's Association took the opportunity to launch a short video, where Neuro-SysMed contributes with Professor Tzoulis... Read more
Nephrology meeting Bergen 2023
Bergen Meeting of Nephrology 2023: New Methods in Renal Pathology (20.05.2023)
Autumn renal pathology meeting. Join us!
Newsletter from Neuro-SysMed (16.05.2023)
Get the latest news from Neuro-SysMed in our newsletters!
Image though the microscope.
Collaboration with Tanzania on head and neck cancer (20.04.2023)
The research group of Professor Daniela Costea is currently engaged in a DIKU/NORPART funded collaboration project with partners in Tanzania, establishing immunohistochemistry for p16 as a method for more precise diagnostic of head and neck cancers (HNC). CCBIO has just had a visit from Tanzania, and Professor Costea has just returned from a 2 week stay in Dar Es Salaam where she worked with... Read more
Group photo of some of the participants and teachers.
A Harvard learning experience in Bergen (19.04.2023)
The INTPART-II Flagship-course CCBIO907 Cancer-Related Vascular Biology took place in Bergen March 24th to March 31st 2023, with fortunate students from UiB and a couple of visiting students from abroad who got the opportunity to learn from and connect with excellent Harvard Medical School faculty on campus in Bergen.
A stack of journals on a table.
Current articles from CCBIO PIs in high impact journals (01.02.2023)
CCBIO would like to highlight recent publications in high impact journals.
Microscopy image of AML cells.
Blood sample 24 hours after start of chemotherapy predicts survival (13.01.2023)
Acute myeloid leukemia is an aggressive blood cancer with poor survival. Younger and otherwise healthy patients undergo severe chemotherapy, often accompanied by stem cell transplant, even though it is difficult to predict who will benefit from the treatment. Now, a simple blood test can measure whether the patient's cancer will respond to chemotherapy. If the chemo has no effect, critical weeks... Read more
Portrait of Carina Strell.
Pioneer project increasing the efficacy of immunotherapy (14.12.2022)
The Norwegian Cancer Society has a new funding program, the Norwegian Cancer Society Pioneer Projects, which supports early-stage exploration of novel and innovative ideas with potential for breaking new grounds in cancer research. CCBIO Associate Investigator Carina Strell just got the news that she is awarded with funding from this program for her project "ImSignal – Mapping active immune... Read more
Arne Östman standing in front of a CCBIO poster.
Potential biomarkers and drugs for common breast cancer (13.12.2022)
Professor Arne Östman in CCBIO's International Faculty receives financial support from the Western Norway regional health authorities Helse Vest in their 2023 allocation. His project "Novel biomarkers and combination treatments for ER+ breast cancer" receives NOK 1.500.000 in the first year.
Oddbjørn Straume sitting in his office.
Support to immunotherapy improving project (13.12.2022)
November 26, the regional health authorities Helse Vest announced their funding for 2023, allocating 182 million NOK to 57 new projects, and renewed support to 160 fellows and projects. Among the new projects, CCBIO PI Oddbjørn Straume receives open project support for his project "Targeting AXL to improve immunotherapy: Deep clinical biomarker analysis for precision medicine." The funding... Read more
Portrait photos.
Michael J. Fox Foundation funding to Professor Tzoulis (09.12.2022)
Professor Charalampos Tzoulis receives $300,000 (3MNOK) from the prestigious Michael J. Fox Foundation.
Collage of photos from the Scanpath meeting, with people interacting.
Record attendance at this year’s SCANPATH meeting (30.11.2022)
CCBIO hosted the 6th SCANPATH meeting – Scandinavian Seminar on Translational Pathology – on November 14 and 15 at Solstrand Hotel, close to Bergen (Norway). Top Scandinavian tumor pathologist and pre-clinical scientists came to present and discuss tissue-based studies of tumor mechanisms and biomarker mapping. SCANPATH is a well-established annual forum and has been a successful CCBIO initiative... Read more
Portrait of Kvistad with a brain illustration background, and the NeuroSysMed logo.
Helse Vest grants for 2023 to all four Neuro-SysMed disease programs (29.11.2022)
The regional health authorities, Helse Vest, just released their latest funding results in which 7 Neuro-SysMed projects will receive funding for a total of ~26 Million NOK. This will secure support for important clinical treatment research focusing on multiple sclerosis (MS), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and dementia.
Photo of a slide of Christiane's presentaion and her on the stage giving a talk.
Cancer research grant to PhD Candidate Christiane H. Gjerde (28.11.2022)
Christiane Helgestad Gjerde, PhD candidate in the Bjørge and McCormack groups at CCBIO and the Department of Clinical Science, was awarded with the Kolbjørn Brambani Cancer Research Grant 2022 at the Onkologisk Forum meeting November 17.
Kjell-Morten posing with the diploma and flowers.
Helse Vest Research Award 2022 to Kjell-Morten Myhr (18.11.2022)
Helse Vest, the regional health authorities, has recently announced their 2022 awards, where Kjell-Morten Myhr received the Research Award 2022 for his outstanding work on Multiple Sclerosis research.
Lots of people holding each their gear which fits together as a whole machinery.
It takes a village to run an online course (31.10.2022)
The course CCBIO905 – Methods in Cancer Biomarker Research was arranged for the fourth time September 27-29, 2022. This was the second time as a fully digital event. From the confusion of the first pandemic months, CCBIO is now highly experienced in organizing digital events, and hybrid events, for that matter. One thing is however clear – it takes a village to run a good online course!

Pages